v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Sales, net of returns and allowances $ 1,339,295 $ 1,693,415
Cost of sales 7,442,778 5,328,119
Gross loss (6,103,483) (3,634,704)
Operating expenses    
Selling, general and administrative 14,095,278 14,689,843
Research and development 3,527,911 7,224,849
Total operating expenses 17,623,189 21,914,692
Loss from operations (23,726,672) (25,549,396)
Interest income (expense), net (5,429,115) 550,359
Loss before benefit for income taxes (29,155,787) (24,999,037)
Benefit for income taxes 0 0
Net loss $ (29,155,787) $ (24,999,037)
Net loss per share of common stock    
Basic (in usd per share) $ (0.10) $ (0.15)
Diluted (in usd per share) $ (0.10) $ (0.15)
Weighted average shares used in computing net loss per share of common stock    
Basic (in shares) 302,607,192 167,144,351
Diluted (in shares) 302,607,192 167,144,351

Source